INTECH Investment Management’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$291K	Sell	14,502 -5,601	-28%	-$112K	﹤0.01%	1880
2025 Q1	$396K	Buy	20,103 +3,781	+23%	+$74.4K	﹤0.01%	1747
2024 Q4	$367K	Buy	+16,322	New	+$367K	﹤0.01%	1732